Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominick J Angiolillo

Showing results (181-190 of 760) with videos related to

Pageof 76
Sort By:
Expert Opinion on Drug Safety|August 5, 2023
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromesGiovanni Occhipinti, Antonio Greco, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 12, 2011
Clopidogrel-drug interactionsEric R Bates, Wei C Lau, Dominick J Angiolillo
Circulation|March 29, 2021
Letter by Angiolillo et al Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial"Dominick J Angiolillo, Deepak L Bhatt, Gregg W Stone
Trends in Cardiovascular Medicine|February 2, 2012
Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromesJosé Luis Ferreiro, Angel R Cequier, Dominick J Angiolillo
The International Journal of Cardiovascular Imaging|April 29, 2005
Imaging of atherosclerotic plaqueMario A Pulido, Dominick J Angiolillo, Marco A Costa
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2023
DAPT guided by platelet function tests or genotyping after PCI: pros and consDominick J Angiolillo, Mattia Galli, Antonio Landi, et al.
Expert Opinion on Pharmacotherapy|June 17, 2016
Dual antiplatelet therapy after coronary stentingYongwhi Park, Francesco Franchi, Fabiana Rollini, et al.
Expert Opinion on Pharmacotherapy|January 24, 2023
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationAntonio Greco, Simone Finocchiaro, Dominick J Angiolillo, et al.
Expert Review of Cardiovascular Therapy|August 7, 2019
Aspirin for the primary prevention of cardiovascular disease: latest evidenceDavide Capodanno, Salvatore Ingala, Dario Calderone, et al.
Journal of Thrombosis and Thrombolysis|November 13, 2012
Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practiceAntonio Tello-Montoliu, Naveen A Seecheran, Dominick J Angiolillo
Pageof 76

Showing results (181-190 of 760) with videos related to

Sort By:
Pageof 76
Expert Opinion on Drug Safety|August 5, 2023
Gender differences in efficacy and safety of antiplatelet strategies for acute coronary syndromesGiovanni Occhipinti, Antonio Greco, Dominick J Angiolillo, et al.
Journal of the American College of Cardiology|March 12, 2011
Clopidogrel-drug interactionsEric R Bates, Wei C Lau, Dominick J Angiolillo
Circulation|March 29, 2021
Letter by Angiolillo et al Regarding Article, "Cangrelor, Tirofiban, and Chewed or Standard Prasugrel Regimens in Patients With ST-Segment-Elevation Myocardial Infarction: Primary Results of the FABOLUS FASTER Trial"Dominick J Angiolillo, Deepak L Bhatt, Gregg W Stone
Trends in Cardiovascular Medicine|February 2, 2012
Oral antiplatelet therapy in patients with diabetes mellitus and acute coronary syndromesJosé Luis Ferreiro, Angel R Cequier, Dominick J Angiolillo
The International Journal of Cardiovascular Imaging|April 29, 2005
Imaging of atherosclerotic plaqueMario A Pulido, Dominick J Angiolillo, Marco A Costa
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2023
DAPT guided by platelet function tests or genotyping after PCI: pros and consDominick J Angiolillo, Mattia Galli, Antonio Landi, et al.
Expert Opinion on Pharmacotherapy|June 17, 2016
Dual antiplatelet therapy after coronary stentingYongwhi Park, Francesco Franchi, Fabiana Rollini, et al.
Expert Opinion on Pharmacotherapy|January 24, 2023
Advances in the available pharmacotherapy for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationAntonio Greco, Simone Finocchiaro, Dominick J Angiolillo, et al.
Expert Review of Cardiovascular Therapy|August 7, 2019
Aspirin for the primary prevention of cardiovascular disease: latest evidenceDavide Capodanno, Salvatore Ingala, Dario Calderone, et al.
Journal of Thrombosis and Thrombolysis|November 13, 2012
Successful pregnancy and delivery on prasugrel treatment: considerations for the use of dual antiplatelet therapy during pregnancy in clinical practiceAntonio Tello-Montoliu, Naveen A Seecheran, Dominick J Angiolillo
Pageof 76